Phase II study of c-raf kinase antisense oligonucleotide ISIS 5132 in patients (pts) with recurrent ovarian cancer - NCICIND.116. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Oza, AM
  • Eisenhauer, E
  • Swenerton, K
  • Elit, Laurie
  • Ghatage, P
  • Carey, M
  • Faught, W
  • McIntosh, L
  • Dorr, A
  • Holmlund, J

publication date

  • November 1, 2000